Method of determining mb creatinekinase in blood serum

专利摘要:
The invention relates to a method for determining the activity of creatine phosphinase MB (CK-MB) in serum. The purpose of the invention is to improve the accuracy of determination of creatine kinase MB in the shortening of blood. For this, SC-MB is determined by immunological exclusion of group M and measurement of group B by known methods for the determination of creatine kinase. Group M is excluded in the reaction mixture from antibodies against group M, monovalent fragments obtained by proteolytic cleavage under reducing conditions are added. Fragments are not only inhibited by natural antibodies that belong to the IgG fraction or to the j-globulins and have molecular mass 130.000-210.000, but also FAB fragments resulting from. proteolytic cleavage, from the IgG or -globulin fraction of the antiserum to creatine kinase MM, and they are pretreated with acetamide of iodine. 1 tab. (O CO
公开号:SU1336941A3
申请号:SU802891744
申请日:1980-02-29
公开日:1987-09-07
发明作者:Грубер Вольфганг；Ленц Хельмут；Лоозер Зигфрид；Линке Ханс-Ральф
申请人:Берингер Маннхайм Гмбх (Фирма)；
IPC主号:

专利说明:

1I
The invention relates to a method for determining the activity of creatine phosphonase MB, called CK-MB, in short.
The aim of the invention is to improve the accuracy of determination of creatine kinase MB in the shortening of blood.
The method is carried out as follows.
The method of determining krease kinase MB in short is carried out by immunological exclusion of group M and measuring group B by known methods for determining creatine kinase. To eliminate the M group, monovalent fragments obtained by proteolytic cleavage under reducing conditions are added to the reaction mixture from antibodies against the M group.
Enzymes are inhibited not only by natural antibodies that belong to the IgG fraction or to -globulins and have a molecular weight of about 130,000-210,000, but also by FAB fragments resulting from proteolytic cleavage.
Example. Getting IgG-fraction.
Sheep sheep that were immunized with human SC-MM (small enzyme type) were mixed with crystalline ammonium sulfate at 0-4 ° C and pH 7 to 1.8 M. After centrifugation, the precipitate was dissolved in 0.1 M TPIS / 0, 15 M NaCl buffer solution, pH 8, and dialyzed against an excess of 10 mM phosphate buffer solution, pH 7.1. Once again, the centrifuged clarified dialysate is applied to the column, which is filled with DEAE-cellulose. The protein-containing stream and eluate, which is obtained with I5 mM phosphate / 1 O mM NaC1 buffer solution, pH 7.1, are combined and contain more than 95% pure IgG.
Cleavage by papain.
IgG is incubated under reducing conditions (I o mM cysteine) with 1.5% papain (wt.% Based on the amount of IgG protein) at pH 7.5 for more than 5 hours at 37 ° C. At the end of the incubation phase, the effect of the enzyme stops an excess of acetamide of iodine and for the alkylation of free SH-groups, incubation was carried out for 2 h at pH 7.5 at room temperature.
0
five
five
0
five
0
five
0
five
The stabilized cleavage mix contains FAB fragments, F, -fragments, and 10% of undigested IgG. The recovery rate of immunoreactivity is more than 75%.
Cleaning FAB fragments.
After concentration to 30 mg / ml by ultrafiltration, the cleavage mixture is separated by gel chromatography. FAB fragments are eluted as the last protein peak, well separated from IgG and F - fragments. The FAB fraction after concentration by ultrafiltration can be applied directly to the inhibition of SC-MM or SC-MB (brain type). The inhibition of the CS-MB (hybrid type) is within the 50% error limit. SC-MM inhibition is 99-100%.
PR and M e p 2. Obtaining a fraction of -globulin nz sheep plasma.
Sheep citrate plasma, which was immunized with CK-MM for 4-6 months, was diluted with 25 mM calcium chloride and placed for approximately 2 hours at room temperature to coagulate. After mechanical crushing, the coagulum is diluted with 1 volume of physiological NaC1 solution and mixed to adsorb the lipoprotein with 2% silicate coagulant (aerosil).
By centrifugation, a transparent top layer is obtained. From the upper layer at 0–4 ° C and at pH 7, it is precipitated with 1.8 M ammonium sulfate fraction of α-globulin and collected by centrifugation. Dialysis with a 50 mM TPIS / 0.1 M NaCl buffer solution, pH 7.5, and ultrafiltration concentration yields an antibody preparation suitable for enzymatic digestion.
Cleavage by papain.
1 each, but some modification for the γ-globulin fraction is carried out. 1.5% papain is related to 1 g of the protein of the α-globulin fraction, and the incubation time is 20 hours at 25 ° C. The rest of the conditions are the same.
Purification of the fab fraction.
The alkylated cleavage mixture is dialyzed against a physiological solution of sodium chloride, then mixed with 25 mM zinc sulphate. As a result
residues of undigested IgG and FJ fragments are precipitated and separated by centrifugation. The remaining FAB fragments after dialysis and concentration are ready for use in the SC-MB test. The yield is more than 80% inhibitory activity for the SC-MM isoenzyme based on the starting plasma. SC-MB is inhibited by 50% regardless of the amount of inhibition for uncleaved antibodies.
The table shows the results obtained with various short.
The proposed method allows, in comparison with the known method, in which the CK-MM brake is fully and CK-MB by 60-90%, to obtain monovalent fragments (FAB-fragments), which brake t. CK-MM, and CK-MV brake t in within the margin of error only to 50%. As a result, it becomes possible to use anti-shorts obtained from the corresponding experimental animals (sheep, rabbit, chicken, etc.) to determine the CK-MB, not selected preliminarily associated with the cost. I.Shulla editor
Compiled by G. Kryukov Tehred L. Serdyukova Proofreader V. But ha
Order 4057/59 Circulation 594 Subscription
VNIIPI USSR State Committee
for inventions and discoveries 113035, Moscow, Zh-35, Rauschska nab., 4/5
Production and printing company, Uzhgorod, st. Project, 4
.
1336941
mi analytical methods of antisera that inhibit SC-MB by approximately more than 53%. It is possible to cleave the horns without the pre-existing determination of their inhibitory properties by proteolytic under reducing conditions and then specifically exclude the M SKM group, specifically with 10 cleavage fragments, regardless of whether there are SC-MM in the endpoint enzyme or SK-MB hybrid enzyme.

权利要求:
Claims (1)
[1]
15 Formula of the invention
A method for detecting creatine kinase MB in short blood by treating it with antibodies to creatine kinase MM, characterized in that, in order to improve the accuracy of the determination, monovalent F-AB fragments derived from the IgG or y-globulin antiserum to creatine kinase are used as antibodies MM, while they are pre-treated with acetamide iodine.

类似技术:

---

公开号 | 公开日 | 专利标题

---

Oertel et al.1981|Production of a specific antiserum to rat brain glutamic acid decar☐ ylase by injection of an antigen-antibody complex

---

Eshhar et al.1974|Ferritin, a Hodgkin's disease associated antigen

---

US4067775A|1978-01-10|Process and composition for determining the activity of creatinekinase-MB

---

Rudikoff et al.1972|Crystals of phosphorylcholine-binding Fab-fragments from mouse myeloma proteins: preparation and x-ray analysis

---

US4012285A|1977-03-15|Analysis of isoenzyme patterns

---

Fechheimer et al.1982|Phosphorylation of lymphocyte myosin catalyzed in vitro and in intact cells.

---

US4366242A|1982-12-28|Method and agent for the immunological determination of enzymes

---

Werner1974|Isolation and characterisation of a mitochondrially synthesized precursor protein of cytochrome oxidase

---

US4387160A|1983-06-07|Immunochemical assay for creatine kinase-MB isoenzyme

---

Väänänen et al.1985|Purification and localization of human carbonic anhydrase

---

Stevens et al.1976|Microheterogeneity of arylsulfatase A from human tissues

---

SU1336941A3|1987-09-07|Method of determining mb creatinekinase in blood serum

---

US4780410A|1988-10-25|Sandwich enzyme immunoassay for PIVKA-II with monoclonal anti-PIVKA-II antibody

---

Sakamoto et al.1978|Mouse bone collagenase: purification of the enzyme by heparin-substituted Sepharose 4B affinity chromatography and preparation of specific antibody to the enzyme

---

Schrohenloher1963|The degradation of human γ-globulin by trypsin

---

Bray et al.1971|Argininosuccinase from bovine kidney: comparison of catalytic, physical, and chemical properties with the enzyme from bovine liver

---

EP0190711B1|1989-04-26|Monoclonal antibodies to tissue plasminogen activator derived from human normal cells

---

Kumpulainen et al.1978|Immunohistochemical demonstration of carbonic anhydrase

---

Kahn et al.1976|Pyruvate kinase isozymes in man

---

Penn et al.1972|Myosin from normal and dystrophic human muscle: Immunochemical and electrophoretic studies

---

Thorpe et al.1966|Studies on papain produced subunits of human γG-globulins—I: Physicochemical and immunochemical properties of γG-globulin Fc-fragments

---

Morin1979|Creatine kinase isoenzyme--antibody reactions in immuno-inhibition and immunonephelometry.

---

MALM et al.1987|Inhibition of human vitamin‐K‐dependent protein‐S‐cofactor activity by a monoclonal antibody specific for a Ca2+‐dependent epitope

---

Roberts et al.1973|Antibody to prolyl hydroxylase from rat skin and its cross-reactivity with enzyme from other species

---

Suld et al.1970|Immunological Studies on Guinea Pig Serum and Liver l-Asparaginases: PURIFICATION OF l-ASPARAGINASES BY ANTIBODY PRECIPITATION

同族专利:

---

公开号 | 公开日

---

DK154459B|1988-11-14|

---

DE2908053C2|1982-08-19|

---

FI72145B|1986-12-31|

---

ZA801158B|1981-03-25|

---

AR219440A1|1980-08-15|

---

CA1160942A|1984-01-24|

---

IE800221L|1980-09-02|

---

AT263T|1981-10-15|

---

EP0015508A1|1980-09-17|

---

AU515930B2|1981-05-07|

---

DK63680A|1980-09-03|

---

IE49158B1|1985-08-07|

---

YU42965B|1989-02-28|

---

DE3060050D1|1981-12-10|

---

FI800577A|1980-09-03|

---

JPS5820274B2|1983-04-22|

---

EP0015508B1|1981-09-30|

---

DE2908053A1|1980-09-11|

---

US4330620A|1982-05-18|

---

DK154459C|1989-05-22|

---

CS226407B2|1984-03-19|

---

FI72145C|1987-04-13|

---

AU5549680A|1981-03-12|

---

HU181684B|1983-11-28|

---

YU54280A|1984-10-31|

---

JPS55120797A|1980-09-17|

---

DD149421A5|1981-07-08|

---

ES488774A1|1980-09-16|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

DE2128670B2|1971-06-09|1977-06-30|Merck Patent Gmbh, 6100 Darmstadt|IMMUNOLOGICAL ISOENZYME DETERMINATION METHOD|

---

US4001088A|1974-08-02|1977-01-04|Antonik Alan S|Method for the determination of creatine phosphokinase enzyme|

---

DE2548963C3|1975-11-03|1982-03-11|Merck Patent Gmbh, 6100 Darmstadt|Method and means for determining the activity of creatine kinase MB|

---

DE2548962C2|1975-11-03|1985-11-21|Merck Patent Gmbh, 6100 Darmstadt|Antibodies against subunit M of creatine kinase isoenzymes|

---

JPS5344622A|1976-09-30|1978-04-21|Mochida Pharm Co Ltd|Immunologically measuring method|

---

DE2828658C3|1978-06-29|1981-10-22|Lkb-Produkter Ab, Stockholm|Method for the photometric determination of subunit B of creatine kinase and reagent therefor|US4614712A|1983-02-25|1986-09-30|The Upjohn Company|Immunoassays with luciferase labeled ligands or receptors|

---

CA1260828A|1983-07-04|1989-09-26|Masakazu Iwai|Therapeutic and prophylactic agent forgastrointestinal ulcers|

---

JPS60125565A|1983-12-12|1985-07-04|Amano Pharmaceut Co Ltd|Method for fractionation and quantitative determination of enolase sub-unit|

---

US4810639A|1985-12-20|1989-03-07|E. I. Du Pont De Nemours And Company|Immunoassay for CK-MB using bound and soluble antibodies|

---

JPS63131065A|1986-11-20|1988-06-03|Yatoron:Kk|Refining of antibody, measurement of isozyme and reagent|

法律状态:

优先权:

---

申请号 | 申请日 | 专利标题

---

DE2908053A|DE2908053C2|1979-03-02|1979-03-02|Method and reagent for the determination of creatine kinase MB|

---